Members of the Nuclear eXport Factor (NXF) family are involved in the export of mRNA from the nucleus to the cytoplasm, or hypothesized to play a role in transport of cytoplasmic mRNA. We previously reported on the loss of NXF5 in a male patient with a syndromic form of intellectual disability. To study the functional role of NXF5 we identified the mouse counterpart. Based on synteny, mouse Nxf2 is the ortholog of human NXF5. However, we provide several lines of evidence that mouse Nxf7 is the actual functional equivalent of NXF5. Both Nxf7 and NXF5 are predominantly expressed in the brain, show cytoplasmic localization, and present as granules in neuronal dendrites suggesting a role in cytoplasmic mRNA metabolism in neurons. Nxf7 was primarily detected in the pyramidal cells of the hippocampus and in layer V of the cortex. Similar to human NXF2, mouse Nxf2 is highly expressed in testis and shows a nuclear localization. Interestingly, these findings point to a different evolutionary path for both NXF genes in human and mouse. We thus generated and validated Nxf7 knockout mice, which were fertile and did not present any gross anatomical or morphological abnormalities. Expression profiling in the hippocampus and the cortex did not reveal significant changes between wild-type and Nxf7 knockout mice. However, impaired spatial memory was observed in these KO mice when evaluated in the Morris water maze test. In conclusion, our findings provide strong evidence that mouse Nxf7 is the functional counterpart of human NXF5, which might play a critical role in mRNA metabolism in the brain. 
Introduction
Members of the Nuclear Export Factor (NXF) family play a crucial role in the export of processed mRNA from the nucleus to the cytoplasm [1] . In human, four functional NXF family members have been described of which three cluster on Xq22.1 [2, 3] . The ubiquitously expressed NXF1, which is located on chromosome 11, codes for the predominant mRNA nuclear export factor [1] . Tissue distribution of NXF2 and NXF3 appears to be restricted to the testis [4] , whereas NXF5 mRNA could be detected in fetal brain and hippocampus [2] . Subcellular localization revealed that NXF1 and NXF2 are predominantly nuclear, whereas the cytoplasmic presence of NXF3 and NXF5 suggests that they have a different cellular function [2, 3] . Both NXF1 and NXF2 bind mRNA, interact with NXT/p15 as well as with nucleoporins, and display RNA nuclear export activity [5] . NXF3 also has the ability to export mRNA from the nucleus to the cytoplasm but it uses an entirely different mechanism [4] . For NXF5 however, no export activity was reported although it binds non-specifically to RNA but not to nucleoporins [2] .
Apart from the autosomal Nxf1 gene the mouse also has three additional Nxf genes that cluster on the X chromosome (Nxf2, Nxf3 and Nxf7). Clear orthology was established for human NXF3 and mouse Nxf3 [6] but the relationships of Nxf2 and Nxf7 to their human counterpart remained uncertain. Mouse Nxf2 localizes to the nucleus while Nxf7 is cytoplasmic [7, 8] . Furthermore, Nxf2 but not Nxf7, exports mRNA from the nucleus [8, 9] . These functional characteristics pointed towards mouse Nxf7 as the functional equivalent of human NXF5. However, while mouse Nxf2 shows highest expression in the testis with a crucial role in spermatogenesis [10] , it is also expressed in the brain as detected at mRNA [8] and protein levels [7] . Nxf7 mRNA transcripts on the other hand, were exclusively detected in brain [2, 8] . Interestingly, Nxf7 was suggested to play a role in dendritic mRNA transport, stability or storage [9, 11] . For Nxf2 a role in mRNA dynamics in neurons was proposed based on its interaction with motor proteins [12] .
We previously reported on an intellectually disabled (ID) patient who lacks NXF5 due to a pericentric inversion on the X chromosome [2] . Because of its proposed functional characteristics, deletion of NXF5 could well account for the ID observed in our patient. We identified Nxf7 as the functional mouse counterpart for human NXF5 and generated an Nxf7 knockout (KO) mouse by a Cre-loxP-mediated out-of-frame deletion of exon 3. Based on morphological, histological, molecular and behavioural analyses of these Nxf7 KO mice, we provide strong evidence that Nxf7 is the functional equivalent of NXF5 and that dysfunction of NXF5 could relate to cognitive impairment.
Materials and Methods

Nxf Genomic and mRNA Expression Analysis
Genomic analysis of the human and mouse NXF/Nxf gene clusters was performed using information from the Ensembl (http://www.ensembl.org/) and UCSC (http://genome.ucsc.edu/ ) web browsers. Genomic and cDNA sequences were analyzed in VectorNTi (Lifetechnologies). Primer sequences for regular and quantitative PCR (qPCR) were purchased from IDT (Integrated DNA technologies, Haasrode, Belgium) and can be found in Table  S1 . Human NXF gene expression was measured from purchased total RNA from different tissues (Lifetechnologies) while for mouse Nxf genes, total RNA was extracted from tissues of C57Bl/6 mice with Trizol (Lifetechnologies) and treated with DNaseI. cDNA synthesis and qPCR was performed as described earlier [13] . For regular PCR, primers were chosen within or flanking exon 3 to discriminate between wild type (WT) and KO loci. qPCR was performed as described earlier [13] using SYBRgreen on a LC480 instrument (Roche). Relative quantitation by qPCR of NXF/Nxf expression (exon 10-11 for NXF2; exon 15 for NXF5; exon 21-22 for Nxf2; exon 3-4 and exon 21-22 for Nxf7) was normalized towards the housekeeping genes GUSB/Gusb and HPRT1/Hprt1. Genomic DNA contamination was excluded using a non-reversetranscribed RNA sample. Equal amplification efficiencies of qPCR primer sets for Nxf2 and Nxf7 were demonstrated by qPCR on equal amounts of plasmid constructs (data not shown). qPCR primers were chosen in regions present in all known Nxf transcripts.
The different mouse Nxf genes were cloned from cDNA obtained from testis (Nxf2 and Nxf3) and brain (Nxf1 and Nxf7) tissues and cloned into the pBluescript-KS (Stratagene) or pEGFP-C1 (Clontech) vectors.
Generation of Nxf7 KO Mouse and Genotyping
We selected the Nxf7 exon 3 for targeted deletion because of the minimum amount of sequence similarity with the other Nxf genes, it is included in both reported Nxf7 isoforms, and is predicted to result in an out-of-frame transcript. A genomic mouse Nxf7 genecontaining clone of 129 Sv genetic background was obtained by screening a BAC library with a 429 bp Nxf7-specific probe. From the single positive BAC clone (449B22), a 6.5 kb BamHI fragment containing exon 1 to exon 5 was cloned in the pUC18 vector. From this construct, a 2.3 kb SalI/BamHI fragment harbouring exons 3 to 5 was subcloned into pUC18. Subsequently, a loxP-frt-PGK promoter-Hygromycin B (Hyg)-frt cassette was cloned into the EcoRV site of intron 2, and a loxP site was inserted into a blunted BglII site within intron 3 of the Nxf7 gene. In this way, exon 3 was flanked by two loxP sites with a Hyg selection marker in between both loxP sites (Fig. S1 ). Finally, a 4.2 kb BamHI/SalI fragment which harbours exons 1 and 2 was re-ligated using the SalI site in intron 2. This final construct carries 5 kb Nxf7 genomic sequences upstream of the proximal loxP site and 1 kb downstream of the distal loxP site. 129 Sv ES cells were electroporated with the construct and after Hyg selection cells were cloned by limiting dilution and grown in 96-well plates. ES clones were grown in duplicated plates and DNA was extracted from one set. Positive clones resulting from homologous recombination were identified by PCR using a forward primer within the distal loxP site and the reverse primer in exon 6, not included in the construct. From the 196 clones screened, two (clones 54 and 175) were positive (1% efficiency). Southern blot with a 429 bp Nxf7 59-probe on PstI-digested genomic DNA of both positive clones demonstrated correct targeted recombination of the fragment without any additional unexpected bands (Fig. S1) . Next, clone 54 was injected in blastocysts of a C57Bl/6 mouse as described elsewhere [14] . Chimeric offspring were checked by PCR as described above and positive males were used for further breeding with C57Bl/6 female mice. Subsequent, to successful germline transmission these mice were crossed with female C57Bl/ 6 mice expressing Cre recombinase from the ubiquitous PGK promoter. For genotyping, DNA from tail fibroblasts was isolated and PCR was performed with three primer pairs resulting in reliable discrimination (Fig. S2 ). Primer sequences can be found in Table S1 . Mice were bred into the C57Bl/6 background for at least 10 generations. Standard breeding was done by crossing heterozygous (HTZ) Nxf7 females with C57Bl/6 WT males. In this breeding scheme we observed the following numbers of offspring per genotype out of a total of 259 pups: 45 KO males (17%), 78 WT males (30%), 57 HTZ females (22%) and 79 WT females (31%), which is significantly different from the predicted Mendelian segregation (p = 0.02). The successful mating of male KO mice with C57Bl/6 WT females and female KO mice with C57Bl/6 WT males demonstrated that these animals are fertile.
Immunohistology, Immunofluorescence and In Situ hybridization
Six week old WT and KO male mice were anesthetized and transcardially perfused with 4% paraformaldehyde in PBS. Immunostaining of paraffin-embedded brain slices was done with hematoxylin and eosin (HE; Merck). Staining of neurons was performed with anti-NeuN antibody (1/4000; Chemicon) followed by biotinylated rabbit anti-mouse antibody (1/400; Sigma), and peroxidase-labeled streptavidine (1/100; Perkin Elmer) according to standard procedures. Stained sections were analyzed with an Axioplan2 fluorescent microscope (Carl Zeiss, Göttingen, Germany) and inspected for morphological alterations in the brains of KO mice. Immunofluorescence for Nxf7 was performed on 6 mm thick paraffin brain sections from WT and Nxf7 KO mice. Polyclonal anti-Nxf7-Nt Ab (1:200; see below) was incubated overnight. As a secondary antibody we used an Alexa Fluor 568 goat anti-rabbit IgG. Whole mount and tissue slice in situ hybridizations were performed as described previously [15] using DIG-UTP-labeled Nxf2-and Nxf7-specific RNA riboprobes and visualized with an anti-DIG-Cy3 Ab or with NBT/BCIP as described elsewhere [16] .
Microarray Expression Analysis
For microarray expression analysis, hippocampi and cortices were dissected from 6-week old WT and Nxf7 KO male mice. RNA concentration and integrity was assessed using a Bioanalyzer 2100 (Agilent). Per sample, an amount of 1 mg of total RNA spiked with 10 viral polyA transcript controls (Agilent) was converted to double stranded cDNA in a reverse transcription reaction. Subsequently, the samples were converted to antisense cRNA, amplified and labeled with Cyanine 3-CTP (Cy3) or Cyanine 5-CTP (Cy5) in an in vitro transcription reaction according to the manufacturer's protocol (Agilent). Cy5-and Cy3-labeled samples were co-hybridised in a loop-design fashion (WT1/KO1, KO1/ WT2, WT2/KO2 and KO2/WT1) on Agilent Mouse Whole Genome arrays. Arrays were scanned with the Agilent DNA MicroArray Scanner with Surescan High-Resolution Technology and probe signals were quantified using Agilent's Feature Extraction software (version 10.1.1.1). Statistical data analysis was performed on the processed Cy3 and Cy5 intensities, as provided by the Feature Extraction Software version 10.1. Probes with none of the eight signals flagged as positive and significant (by the Feature Extraction Software) were omitted from all subsequent analyses as well as the various controls. R was used in combination with the limma package to perform the microarray data analysis [17, 18] . Subsequently, the contrast between the KO and WT samples was extracted. Testing whether a contrast is significantly different from 0 was done by using a moderated t-statistic, as implemented in Limma. Probes with a p-value smaller than 0.001 and an absolute fold-change larger than 2, were selected as differentially expressed. The data can be found in the Gene Expression Omnibus (GEO) database under accession number GSE29541.
Western Blot
Since no commercial antibodies (Abs) against Nxf7 were available, we generated polyclonal antibodies in rabbits using standard immunization protocols. We produced Nxf7-specific Abs against the two domains that differ most from the other Nxf proteins; the N-terminal amino acids 1-91 (Nxf7-Nt) and the Cterminal 368-619 fragment (Nxf7-Ct). Rabbits were injected three times and the specificity of the final antiserum was tested on lysates of HEK293T cells transfected with flag-tagged Nxf1, Nxf2, Nxf3 or Nxf7 constructs cloned into pcDNA3.1 (Lifetechnologies). Anti-flag Ab (Sigma) was used to check the transfection efficiency. For the anti-Nxf7 Abs, peroxidase-conjugated goat anti-rabbit Ig was used as the second Ab. Signals were visualized with the LAS-3000 Imaging System (Fujifilm Global). Cortical and hippocampal protein lysates (30 mg) were analyzed according to standard procedures. Protein lysates were also prepared from dissected yolk sacs from embryos of a pregnant Nxf7 HTZ female, mated with an Nxf7 KO male. Genotyping was performed on DNA extracted from the tails of the embryos as described earlier. Western blot was performed on 30 mg of protein lysates separated on a 4-12% NUPAGE bis-Tris gel (Lifetechnologies). The Nxf7-Ct Ab was used as the primary Ab.
Behavioural Assays
To assess neuromotor abilities, motor coordination on the accelerating rotarod and grip strength were recorded as described earlier [19] .
Male Nxf7-deficient (Nxf7 KO, n = 21) mice and their wild-type (WT, n = 20) littermates (age 2-3 months) were compared in a hippocampus-dependent spatial learning test [19] . Animals were kept in standard animal cages under conventional laboratory conditions (12 h/12 h light-dark cycle, 22uC), with ad libitum access to food and water. Experiments were conducted during the light phase of the activity cycle. Hippocampus-dependent spatial memory abilities were examined in the standard hidden-platform acquisition and retention (i.e., long-term memory) versions of the Morris maze [20] . A 150 cm circular pool was filled with water, opacified with non-toxic white paint, and kept at 26uC as previously described [19] . A 15 cm round platform was hidden 1 cm beneath the surface of the water at a fixed position. Each daily trial block consisted of 4 swimming trials (10 min inter-trial interval) starting randomly from each of 4 starting positions. Mice that failed to find the platform within 2 min were guided to the platform, where they remained for 15 s before being returned to their cages. To test spatial memory, probe trials (100 s) by removing the platform were conducted at the end of a working week. Time spent in target quadrant compared to chance level (25%) was used as measure for long-term retention memory. Swimming paths of the animals were recorded using EthoVision video tracking equipment and software (Noldus bv, Wageningen, The Netherlands). Statistical analysis was performed using SigmaStat for Windows 3.11 or GraphPad Prism 5.0. Data are presented as means 6 SEMs. Differences between groups were statistically analyzed by Student's t-test, one sample t-test, or twoway repeated measures ANOVA when appropriate, with the power of alpha set at 0.05. For post hoc comparison, multivariate analysis with Holmes-Sidak corrections was performed.
Results
Mouse Nxf7 is the Ortholog of Human NXF5
The three functional human NXF genes cluster in a 1.27 Mb interval (101.08 to 102.35 Mb) in the orientation Xcen-NXF5-NXF2-NXF3-Xqter (UCSC build hg19, Feb 2009). The mouse syntenic region covers 1.22 Mb (131.46 to 132.68 Mb) (UCSC build mm9, July 2007) in the orientation Xcen-Nxf2-Nxf7-Nxf3-Xqter. Therefore, the syntenic regions including the additional genes located in between the NXF/Nxf genes, strongly indicate that the human NXF5, NXF2 and NXF3 genes are the orthologs of mouse Nxf2, Nxf7 and Nxf3, respectively (illustrated in Fig. S3) . Indeed, the UCSC genome browser points to NXF5 as the ortholog for Nxf2, while NXF2 is indicated to be the ortholog for Nxf7. However, based on literature and protein alignments (Fig.  S4 ) their functional relations remained unclear. First, we evaluated theexpression of mouse Nxf genes in different tissues, since contradictory results have been reported in the literature. By regular PCR, mouse Nxf2 and Nxf3 showed selective expression in the testis, while Nxf7 mRNA was predominately detected in adult mouse brain and at lower levels in testis (Fig. 1A) . Furthermore, we relatively quantified human NXF2 and NXF5 mRNA levels in hippocampus, whole brain, muscle and testis. NXF5 transcript levels in human hippocampus and whole brain were about 2-fold higher than those of NXF2 (Fig. 1B) . No expression was detected in the muscle as well as other tissues tested (data not shown. In the testis, NXF2 mRNA levels were about 100-fold higher than those of NXF5. We evaluated the same brain regions in the mouse, revealing a 100-fold higher Nxf7 expression in the cortex in comparison to Nxf2 (Fig. 1C) . In the hippocampus, the Nxf7 levels were 32-fold lower than found in cortex and only 1.5-fold higher than Nxf2 levels. However, in the testis Nxf2 mRNA was .15-fold more abundant compared to Nxf7. In the cerebellum, transcript levels were equally low for both Nxf genes (Fig. 1C) . Moreover, expression levels of both genes remained stable in cortex and hippocampus at least during the first 12 weeks of life (data not shown).
To assess the mRNA localization of Nxf2 and Nxf7 more specifically, we performed in situ hybridization (ISH) on whole mouse embryos and embryonic slices (E7.5-E12.5) as well as on sections of adult testis and brain using Nxf2-and Nxf7-specific probes. ISH with the Nxf2 antisense probe did not reveal any staining in the embryo (Fig. 2A,B) . However, strong signals were noticed in the adult testes, more particular in the spermatogoniaforming inner cell layer of the tubuli seminiferi that contain the mature sperm cells (Fig. 2C) . ISH with the Nxf7 antisense probe did not reveal any staining in the E7.5 to E12.5 embryos, but intense and specific staining was observed in extra-embryonic tissues like allantois, yolk sac and membranes of amnion and chorion ( Fig. 2D-H) . qPCR on the allantois and yolk sac confirmed the high Nxf7 levels while Nxf2 was barely detected in these tissues (Fig. 2J) validating our ISH data. In the testis, some Nxf7 staining was noticed in the interstitial cells although signals were low (Fig. 2I) . Finally, ISH with the Nxf7 antisense (Fig. 3) but not the sense probe (Fig. S5 ) revealed a more intense staining in layer V of the cortex, and the pyramidal cells of the CA1 region of the hippocampus. Taken together, the ISH data confirm our qPCR data showing highest expression of Nxf7 in extra-embryonic tissues during early embryogenesis and moderate levels in the brain.
Overexpression of GFP-Nxf fusion genes in human 293T cells was performed to check the subcellular localization of the mouse Nxf proteins. Mouse Nxf1 and Nxf2 clearly localize in the nucleus while Nxf7 stains the cytoplasm of these cells (Fig. S6) . Treatment of the cells with Triton X-100 revealed staining of the nuclear rim for Nxf1 and Nxf2 but not for Nxf7, which demonstrated that Nxf7 does not bind to the nucleoporins of the nuclear membrane. The subcellular localization pattern of Nxf7 is thus comparable with that of NXF5 as previously reported [2] . Combining these findings with our expression data we have strong evidence to conclude that mouse Nxf7 is the functional equivalent of human NXF5.
Generation and Validation of Nxf7-deficient Mice
Nxf7 KO mice were produced via targeted deletion of a floxed Nxf7 exon 3 (illustrated in Fig. 4A ). Deletion of exon 3 was achieved through mating of a knock-in male mouse with female PGK-Cre-expressing mice. For Nxf7 expression analysis in the brain and testis, a first primer pair in exon 1 and 5 yielded a product of 459 bp and 304 bp for the WT and KO alleles, respectively (Fig. 4B) . The second primer set in exon 3 and 5 resulted in a product of 320 bp for the WT allele only, thus demonstrating the absence of exon 3 in the KO mouse. Finally, primers in exon 8 and 16 provided a PCR band of 579 bp for both alleles indicating, as expected, that an exon 3-lacking Nxf7 transcript was produced in the KO mouse irrespective of the premature stop codon in exon 4. qPCR on the Nxf7 KO samples validated the regular PCR data since the Nxf7 primer pair in exon3-4 did not yield any product while the primer pair in exon21-22 showed mRNA abundances that were about half of those detected in the corresponding WT samples (data not shown). At the protein level, we were unable to detect Nxf7 in WT brain samples using our polyclonal antibodies. However, when using WT yolk sac lysate, which has higher levels of Nxf7 mRNA, we could visualize an Nxf7 band at about 65 kDa while no band was observed for the KO samples (Fig. 4C) . Moreover, we did not detect any additional lower band from a potential smaller Nxf7 protein fragment. To provide additional evidence that no alternative protein was produced in the KO mice, we generated an exon 3-lacking Nxf7 construct flanked by a Flag tag at the Nterminal side and an HA tag at its C-terminus. Upon transfection in HEK-293T cells, we did not observe a smaller protein fragment by Western blot using antibodies against both tags (Fig. 4D) . Furthermore, immunofluorescent staining on brain slices of WT and Nxf7 KO mice, revealed a specific staining in the CA1 pyramidal cells of the hippocampus as well as layer V of the cortex in WT but not in Nxf7 KO brains (Fig. 5) , again demonstrating the lack of Nxf7 protein in our Nxf7 KO mouse.
Morphological and Molecular Analysis of Nxf7 KO Mice
Because of the expression of Nxf7 in the brain, we investigated the gross morphology of this tissue using HA and NeuN staining on coronal brain slices of WT and KO mice but we did not find any apparent histological changes (data not shown). Next, expression profiling by microarray analysis of hippocampi and cortices of both genotypes was performed. Data were analyzed for each individual hybridization experiment and log 2 ratios were calculated for each gene. Pairwise comparisons of the ratios for the Nxf7 Knockout Mouse to Study Human NXF5 in ID PLOS ONE | www.plosone.orgdifferent hybridizations were done in order to search for highly similar ratios between WT1/KO1 and WT2/KO2 on the one hand, and KO1/WT2 and KO2/WT1 on the other hand. For the hippocampus, ranking of those ratios with stable but opposite values of WT/KO and KO/WT revealed 19 up-regulated and 4 down-regulated genes with a significant .2-fold change in expression (p,0.001) between WT and KO (Fig. S7A) . Verification of the data was performed for 17 selected genes using qPCR on the original as well as four additional WT and KO samples. From those, 10 genes showed high variability (.5-fold) of mRNA levels between animals of the same genotype making 2-to 3-fold expression differences between WT and KO animals irrelevant. The remaining 7 genes showed differences ,1.5-fold excluding them as significantly different. For the cortex samples we found 16 genes increased .2-fold (p,0.001) in KO samples (Fig. S7B ), but again after qPCR validation no consistently altered mRNA levels were found between both genotypes. Moreover, evaluation of the differentially expressed genes in hippocampus and cortex using Gorilla or Ingenuity Pathway analyses did not reveal any enriched pathways (data not shown). The data for both sets of hybridizations can be found in the Gene Expression Omnibus (GEO) database under accession number GSE29541.
Behavioural Analysis in the Morris Water Maze
We hypothesized that loss of Nxf7 leads to impairment in learning and memory as has been shown in patients with a loss of NXF5. To test this prediction we analyzed the performance of the Nxf7 mouse in the Morris water maze assay. No differences were observed in the rotarod or grip strength assays indicating that gross (neuro)motor functions were not affected in the Nxf7 KO mice. However, spatial learning in the Morris water maze was significantly impaired in the KO compared to WT mice (Fig. 6A) . While there was an overall decrease in latency to find the hidden platform over acquisition days (RM ANOVA effect for factor trial F 9,409 = 23.44, P,0.001), WT mice were more efficient to do so (effect for factor genotype F 1,409 = 4.57, P,0.05). This impairment was not caused by differences in path length or in swim speed (data not shown). When tested for spatial retention memory, WT mice displayed significant target preference during first (P1) and second (P2) probe trial. In contrast, time spent in target quadrant was not significantly different from the Nxf7 KO mice (Fig. 6B) . Both overall path length or swim speed were not different between the genotypes during probe trials (data not shown).
Discussion
We previously reported on a male patient with a syndromic form of ID in whom a pericentric inversion disrupted the NXF5 gene at Xq22 [2, 21] . This patient, who thus lacks the NXF5 gene, shows several prominent clinical characteristics that include severe ID, muscular wasting, anxiety with eye contact avoidance, and poor adaptive functioning [21] . Recently, a female ID patient was described with a 1.1 Mb deletion that also harboured the NXF5 gene, amongst 11 others including NXF2 [22] . Although her phenotype is worse compared to that of the patient lacking only NXF5, common features include severe ID and muscle hypotonia. Moreover, we reported on a patient with moderate ID carrying a 0.8 Mb duplication that harboured 15 genes including NXF5 but no other NXF genes [23] . It has been reported that not only decreased but also increased gene dosages of known XLID genes can result in ID [13, 24, 25] . Consequently, NXF5 represents a strong candidate ID gene. To test this hypothesis, we aimed to evaluate the role of NXF5 in a mouse model, however first needed to pinpoint the murine functional equivalent.
The three protein coding members of the NXF family that locate on the human as well as the murine X chromosome are embedded in a syntenic region with a high conservation of gene content. Based on this organization, human NXF5 appears to be the ortholog of mouse Nxf2, human NXF2 of murine Nxf7, and NXF3 of Nxf3. This synteny suggests that the three NXF/Nxf genes on the X chromosome might have evolved before the divergence of murine and human phylogenetic lines. Notably, two additional NXF genes are located in the human NXF cluster on Xq; the NXF2B gene, which arose from a very recent inverted tandem duplication of NXF2, and the apparent pseudogene NXF4, which lacks an open reading frame. In the mouse genome, all three Nxf genes are in the indirect orientation, while in men, an indirect orientation is present for the NXF5, NXF2B and NXF3 genes, indicating that NXF2B actually is the ancestral NXF2 copy. The genomic exon-intron structure of human NXF5 and NXF3 are very similar to that of mouse Nxf2, Nxf7 and Nxf3. That of NXF2 (B) differs substantially from this common organization. However, when the proposed characteristics of the X-linked NXF/Nxf proteins are taken into account, their functional relation seems to differ from their ancestral synteny. Previous studies established that NXF2/Nxf2 show highest mRNA expression in testis and their protein products are predominantly localized in the nucleus. NXF5/Nxf7 proteins on the other hand, display an extensive cytoplasmic staining with a granular pattern in neurons [2] [3] [4] 8, 11] . We demonstrated by ISH and qPCR, high Nxf7 mRNA levels in extra-embryonic tissues for which its function in these gestational structures remains unknown. In the brain, significant expression levels of Nxf7 mRNA was detected in the pyramidal cell layer of the hippocampus and layer V of the cortex, which was confirmed at the protein level. Although Tan and colleagues detected highest Nxf2 levels in brain tissue by Western blot [7] , our qPCR data corroborated the occurrence of only minor amounts of Nxf2 mRNA in brain compared to approximately 250-fold higher levels in testis. Notably, cortical Nxf7 mRNA expression was about 100-fold higher compared to Nxf2.
As previously reported, the subcellular localization data obtained from transfected EGFP-NXF/Nxf fusion constructs clearly demonstrated a nuclear localization for Nxf2 [7, 8] while Nxf7 is predominantly cytoplasmic [7] [8] [9] 11] , resembling the localization of human NXF2 [3] and NXF5 [2] , respectively. In addition, Nxf2 and NXF2 are present at the nuclear rim, which is not the case for Nxf7 and NXF5 [3] . The proposed functional relation of human NXF5 and mouse Nxf7 is strengthened by the fact that NXF2 and Nxf2 promote mRNA export, whereas NXF5 and Nxf7 do not [2, 3, 7, 8] . Taken together, our data combined with those obtained by others strongly argue in favour of mouse Nxf7 being the functional counterpart of human NXF5, which infers a divergent functional evolution of the NXF/Nxf genes in men and mice.
The Nxf7 knockout mouse was generated by targeted deletion of exon 3. RT-PCR and qPCR on cDNA from male KO mice demonstrated the absence of any exon 3-containing transcript. However, this mutant transcript is still produced, although at lower levels compared to full length Nxf7 mRNA in WT mice. Importantly, exon 3 deletion generates an out-of-frame transcript with a stop codon in exon 4 that precludes formation of a functional protein. These findings point to nonsense-mediated mRNA decay of the mutant transcript in the KO mice. Our inability to detect any Nxf7 protein in the WT cortex by Western blot likely is caused by the modest Nxf7 expression in this tissue and/or due to the low sensitivity of our polyclonal antibodies. Therefore, we used the yolk sac of embryos to demonstrate the absence of Nxf7 in the KO samples. Analysis for a potential Nxf7 protein fragment in the KO mouse, which could have been generated through the use of an alternative start codon in exon 4, was not detected. However, we realize that such a band could have been masked by background signals. Alternatively, transfection of HEK-293T cells with the exon 3-lacking construct did not reveal an N-or C-terminal Nxf7 fragment. Notwithstanding, we cannot firmly exclude the production of an Nxf7 fragment.
Strikingly, microarray analyses did not reveal specific altered transcript levels in the cortex or hippocampus of Nxf7 KO mice compared to WT littermates using a threshold of 2.0 for differential expression. Our data thus seem to demonstrate that the changes in transcript levels are more subtle, or that the transcript profiles in these brain structures do not change upon removal of Nxf7. If so, it could be explained by the fact that Nxf7 plays a role in mRNA transport and/or storage but not in expression, translation or stability. However, analysis of more samples or analysis of the synaptoneurosomes is necessary to further investigate our proposed hypothesis.
Finally, we demonstrated an impairment in spatial learning and memory performance in the Morris water maze test, suggesting impairment in hippocampal functions in the Nxf7 KO mice. This memory deficit could mimic the cognitive defects in NXF5-deficient patients.
In conclusion, we provide strong arguments to state that mouse Nxf7 is the functional equivalent of human NXF5 even though mouse Nxf2 is syntenic with NXF5, suggesting a differential evolutionary path of members of this gene cluster in both species. We then generated an Nxf7 knockout mouse as an animal model to study NXF5 loss-of-function mutations in patients. Initial behavioural character- ization of these mice revealed significantly reduced spatial learning. Given the exclusive localization of Nxf7 in cytoplasmic granules including translating ribosomes, stress granules and P-bodies [9, 11] , its association with hnRNP A3 [11] and its co-localization with the neuronal mRNA transport marker Stau1 [9] , a role for Nxf7 is suggested in mRNA cytoplasmic transport, translation, degradation and/or storage. Therefore, next to FMRP for which its absence results in Fragile-X syndrome [26] , NXF5 seems to be a second IDrelated protein involved in mRNA metabolism in neurons. Identification of associated mRNAs, evaluation of additional differences in behaviour as well as electrophysiological studies in the KO mice might shed light on its presumed role in the brain and establish a potential role in ID or other clinical features observed in our patient. 
